ContractAxonics Modulation Technologies, Inc. • August 28th, 2018 • Surgical & medical instruments & apparatus • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 28th, 2018 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • California
This executive employment agreement (this “Agreement”) is effective as of January 1, 2015 by and between Axonics Modulation Technologies, Inc., A Delaware Corporation (“Company”), and Rinda Sama (“Executive”).
FOURTH AMENDED AND RESTATED SHARE EXCHANGE AGREEMENTShare Exchange Agreement • August 28th, 2018 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
This FOURTH AMENDED AND RESTATED SHARE EXCHANGE AGREEMENT (this “Agreement”), is dated as of June 30, 2017, by and between Axonics Modulation Technologies, Inc., a Delaware corporation, (the “Company”); Biodiscovery 4 FCPR, a fund managed by Edmond de Rothschild Investment Partners (“Biodiscovery”); and Coöperatieve Gilde Healthcare IV U.A. (“Gilde”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively, as the “Parties,” and each of Biodiscovery and Gilde are individually referred to herein as an “Investor” and collectively as the Investors.
AXONICS MODULATION TECHNOLOGIES, INC. STOCK OPTION AGREEMENTStock Option Agreement • August 28th, 2018 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
The Board of Directors of Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), has approved a grant to «First_Name» «Last_Name», an individual (the “Optionee”), of an option (the “Option”) to purchase shares of Common Stock of the Company, $0.0001 par value per share (the “Shares”), pursuant to the Company’s 2014 Stock Incentive Plan as amended from time to time (the “Plan”) and this Stock Option Agreement (the “Option Agreement”), as follows:
SECOND AMENDMENT TO LICENSE AGREEMENTLicense Agreement • August 28th, 2018 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus
This AMENDMENT TO LICENSE AGREEMENT (“Amendment”) is entered into as of February 25, 2014 (the “Amendment Effective Date”), by and between Alfred E. Mann Foundation for Scientific Research (“AMF”) and Axonics Modulation Technologies, Inc., a Delaware corporation (“Licensee”).
LICENSE AGREEMENTLicense Agreement • August 28th, 2018 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • California
This License Agreement (this “Agreement”), dated as of October 1, 2013 (the “Effective Date”), is made by and between the Alfred E. Mann Foundation for Scientific Research (“AMF”), a not-for-profit corporation organized and existing under the laws of the State of California, and Axonics Modulation Technologies, Inc., a Delaware corporation (“Licensee”). AMF and Licensee are sometimes hereinafter referred to each as a “Party” and collectively as the “Parties.”
AXONICS MODULATION TECHNOLOGIES, INC. RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • August 28th, 2018 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
The Board of Directors of Axonics Modulation Technologies, Inc., a Delaware corporation (the “Company”), has approved a grant to «First_ Name» «Last_ Name», an individual (the “Participant”), of restricted shares of Common Stock of the Company, $0.0001 par value per share (the “Shares”), pursuant to the Company’s 2014 Stock Incentive Plan (the “Plan”) and this Restricted Stock Purchase Agreement (the “Purchase Agreement”), as follows:
ContractAxonics Modulation Technologies, Inc. • August 28th, 2018 • Surgical & medical instruments & apparatus • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
SECOND AMENDMENT TO LEASEAxonics Modulation Technologies, Inc. • August 28th, 2018 • Surgical & medical instruments & apparatus
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 28th, 2018 • Axonics Modulation Technologies, Inc. • Surgical & medical instruments & apparatus • California
This executive employment agreement (this “Agreement”) is effective as of July 24, 2018 by and between Axonics Modulation Technologies, Inc., A Delaware Corporation (“Company”), and John Woock, Ph.D. (“Executive”).
